3692 · Hansoh Pharmaceutical Group Company Limited
32.18
HKDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
HK$205.70B
PE
35.70
EV/EBITDA
28.7
DIV Yield
1.2%
Payout Ratio
43%
MQV Rating
2Strong
As at 08/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- Consensus Cheap
- HALO 200
- HALO All
- HALO Balance Sheet
- HALO Earnings Momentum
- HALO Momentum
- HALO Small
Key Fundamentals
EPS 3 yr Growth
113.30%
EBITDA Margin
38.70%
Operating Cashflow
¥7,948m
Free Cash Flow Return
24.60%
ROIC
17.20%
Interest Coverage
NaN
Quick Ratio
8.00
Performance
52 weeks range
Low 28.06 - 44.22
Trade Value (12mth)
US$10,913,431.00
1 week
1.19%
1 month
-5.99%
YTD
-6.92%
1 year
-4.29%
All time high
46.70
Additional Data
Shares Outstanding (Fully Diluted)
6,138m
HALO Sector
Healthcare
Next Company Report Date
30-Mar-27
Next Ex Dividend Date
22-Sep-26
Next Dividend Pay Date
29-Oct-26
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Strong
Garp
Neutral
Mqv Small
Strong
Momentum
Price
Strong
Earnings
Very Strong
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Strong
Balance Sheet
Very Strong
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
19 August 25Flash |
Key Stakeholders
| Name | Title |
| Yu An Sun | Individual |
| Jun Da Cen | Individual |
| Invesco Great Wall Fund Management Co. Ltd. | Joint Venture |
| Aifeng Lyu | Individual |
